Prostate-specific membrane antigen (PSMA) is used as an imaging target for prostate cancer (68Ga-PSMA-PET CT), but PSMA is now known to be expressed in other cancer types including thyroid. The gene discussed is FOLH1; the disease is prostate carcinoma.